Synopsys Stock Buy Hold or Sell Recommendation
SNPS Stock | USD 573.35 10.97 1.88% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Synopsys is 'Strong Hold'. Macroaxis provides Synopsys buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Synopsys positions. The advice algorithm takes into account all of Synopsys' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Synopsys' buy or sell advice are summarized below:
Real Value 520.93 | Target Price 483.61 | Hype Value 572.84 | Market Value 573.35 | Naive Value 584.68 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Synopsys given historical horizon and risk tolerance towards Synopsys. When Macroaxis issues a 'buy' or 'sell' recommendation for Synopsys, the advice is generated through an automated system that utilizes algorithms and statistical models.
Synopsys |
Execute Synopsys Buy or Sell Advice
The Synopsys recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Synopsys. Macroaxis does not own or have any residual interests in Synopsys or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Synopsys' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Hold
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Synopsys Trading Alerts and Improvement Suggestions
Synopsys has a strong financial position based on the latest SEC filings | |
Over 94.0% of the company shares are owned by institutional investors | |
Latest headline from investorplace.com: The 3 Best Tech Stocks to Buy in Q2 2024 |
Synopsys Returns Distribution Density
The distribution of Synopsys' historical returns is an attempt to chart the uncertainty of Synopsys' future price movements. The chart of the probability distribution of Synopsys daily returns describes the distribution of returns around its average expected value. We use Synopsys price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Synopsys returns is essential to provide solid investment advice for Synopsys.
Mean Return | 0.06 | Value At Risk | -3.1 | Potential Upside | 4.30 | Standard Deviation | 2.29 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Synopsys historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Synopsys Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Synopsys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Synopsys backward and forwards among themselves. Synopsys' institutional investor refers to the entity that pools money to purchase Synopsys' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Nuveen Asset Management, Llc | 2023-12-31 | 2.5 M | Norges Bank | 2023-12-31 | 2.5 M | Ameriprise Financial Inc | 2023-12-31 | 1.8 M | Amvescap Plc. | 2023-12-31 | 1.8 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.7 M | Northern Trust Corp | 2023-12-31 | 1.6 M | Legal & General Group Plc | 2023-12-31 | 1.4 M | Amundi | 2023-12-31 | 1.3 M | Alliancebernstein L.p. | 2023-12-31 | 1.3 M | Vanguard Group Inc | 2023-12-31 | 13.6 M | Blackrock Inc | 2023-12-31 | 11.8 M |
Synopsys Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 507.4M | 197.2M | (15.3M) | 21.3M | 24.5M | 44.4M | |
Free Cash Flow | 832.6M | 1.4B | 1.6B | 1.5B | 1.7B | 1.8B | |
Depreciation | 210.0M | 203.7M | 228.4M | 247.1M | 284.2M | 298.4M | |
Other Non Cash Items | 168.4M | 184.6M | 169.3M | 213.1M | 245.1M | 257.3M | |
Capital Expenditures | 158.8M | 95.7M | 139.1M | 191.8M | 220.6M | 231.6M | |
Net Income | 664.3M | 757.5M | 978.4M | 1.2B | 1.4B | 1.5B | |
End Period Cash Flow | 1.2B | 1.4B | 1.4B | 1.4B | 1.7B | 1.7B | |
Change To Netincome | 84.1M | 163.4M | 336.6M | 512.2M | 589.0M | 618.5M | |
Change To Inventory | (55.0M) | (48.0M) | 1.3M | (123.8M) | (111.4M) | (105.8M) | |
Investments | (611K) | (156.5M) | (572.6M) | (482.1M) | (433.9M) | (412.2M) | |
Change Receivables | (8.6M) | (236.8M) | 201.7M | (251.4M) | (226.3M) | (214.9M) | |
Net Borrowings | (331.2M) | (12.4M) | (28.1M) | (76.8M) | (69.2M) | (65.7M) |
Synopsys Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Synopsys or Software sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Synopsys' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Synopsys stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.13 | |
β | Beta against NYSE Composite | 1.48 | |
σ | Overall volatility | 2.22 | |
Ir | Information ratio | -0.03 |
Synopsys Volatility Alert
Synopsys currently demonstrates below-average downside deviation. It has Information Ratio of -0.03 and Jensen Alpha of -0.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Synopsys' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Synopsys' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Synopsys Implied Volatility
Synopsys' implied volatility exposes the market's sentiment of Synopsys stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Synopsys' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Synopsys stock will not fluctuate a lot when Synopsys' options are near their expiration.
Synopsys Fundamentals Vs Peers
Comparing Synopsys' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Synopsys' direct or indirect competition across all of the common fundamentals between Synopsys and the related equities. This way, we can detect undervalued stocks with similar characteristics as Synopsys or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Synopsys' fundamental indicators could also be used in its relative valuation, which is a method of valuing Synopsys by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Synopsys to competition |
Fundamentals | Synopsys | Peer Average |
Return On Equity | 0.23 | -0.31 |
Return On Asset | 0.0875 | -0.14 |
Profit Margin | 0.23 % | (1.27) % |
Operating Margin | 0.22 % | (5.51) % |
Current Valuation | 86.86 B | 16.62 B |
Shares Outstanding | 152.54 M | 571.82 M |
Shares Owned By Insiders | 0.43 % | 10.09 % |
Shares Owned By Institutions | 94.30 % | 39.21 % |
Number Of Shares Shorted | 3.18 M | 4.71 M |
Price To Earning | 50.25 X | 28.72 X |
Price To Book | 13.11 X | 9.51 X |
Price To Sales | 14.27 X | 11.42 X |
Revenue | 5.84 B | 9.43 B |
Gross Profit | 4.08 B | 27.38 B |
EBITDA | 1.67 B | 3.9 B |
Net Income | 1.22 B | 570.98 M |
Cash And Equivalents | 1.53 B | 2.7 B |
Cash Per Share | 10.01 X | 5.01 X |
Total Debt | 687.8 M | 5.32 B |
Debt To Equity | 0.12 % | 48.70 % |
Current Ratio | 1.14 X | 2.16 X |
Book Value Per Share | 43.73 X | 1.93 K |
Cash Flow From Operations | 1.7 B | 971.22 M |
Short Ratio | 2.66 X | 4.00 X |
Earnings Per Share | 9.06 X | 3.12 X |
Price To Earnings To Growth | 2.67 X | 4.89 X |
Target Price | 635.69 | |
Number Of Employees | 20.3 K | 18.84 K |
Beta | 1.06 | -0.15 |
Market Capitalization | 87.46 B | 19.03 B |
Total Asset | 10.33 B | 29.47 B |
Retained Earnings | 6.74 B | 9.33 B |
Working Capital | 445.17 M | 1.48 B |
Note: Exercise or conversion by Roy Vallee of 6666 shares of Synopsys subject to Rule 16b-3 [view details]
Synopsys Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Synopsys . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 26072.27 | |||
Daily Balance Of Power | (0.62) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 579.32 | |||
Day Typical Price | 577.33 | |||
Price Action Indicator | (11.45) | |||
Period Momentum Indicator | (10.97) | |||
Relative Strength Index | 63.1 |
About Synopsys Buy or Sell Advice
When is the right time to buy or sell Synopsys? Buying financial instruments such as Synopsys Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 656.4M | 687.8M | 791.0M | 830.5M | Total Assets | 9.4B | 10.3B | 11.9B | 12.5B |
Use Investing Ideas to Build Portfolios
In addition to having Synopsys in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Insurance Providers Thematic Idea Now
Insurance Providers
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All Next | Launch |
Check out Synopsys Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Synopsys Stock please use our How to Invest in Synopsys guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Synopsys Stock analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Synopsys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synopsys. If investors know Synopsys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synopsys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.651 | Earnings Share 9.06 | Revenue Per Share 40.3 | Quarterly Revenue Growth 0.211 | Return On Assets 0.0875 |
The market value of Synopsys is measured differently than its book value, which is the value of Synopsys that is recorded on the company's balance sheet. Investors also form their own opinion of Synopsys' value that differs from its market value or its book value, called intrinsic value, which is Synopsys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synopsys' market value can be influenced by many factors that don't directly affect Synopsys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synopsys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synopsys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synopsys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.